{"nct_id":"NCT01721746","title":"A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)","status":"COMPLETED","status_verified_date":"2022-03","start_date":"2012-12-21","start_date_type":"ACTUAL","primary_completion_date":"2016-02-16","primary_completion_date_type":"ACTUAL","completion_date":"2020-12-29","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}